Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group.

[1]  N. Willich,et al.  Phase III Results of Adjuvant Radiotherapy Versus “Wait and See” in Patients With pT3 Prostate Cancer Following Radical Prostatectomy (ARO 96-02/AUO AP 09/95) , 2007 .

[2]  Michel Rouzaud,et al.  Endorectal MRI assessment of local relapse after surgery for prostate cancer: A model to define treatment field guidelines for adjuvant radiotherapy in patients at high risk for local failure. , 2007, International journal of radiation oncology, biology, physics.

[3]  F. Fazio,et al.  A reappraisal of the role of vesicourethral anastomosis biopsy in patient candidates for salvage radiation therapy after radical prostatectomy. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  M. Eble,et al.  Influence of the initial rectal distension on posterior margins in primary and postoperative radiotherapy for prostate cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  E. Messing,et al.  Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. , 2006, JAMA.

[6]  P. Franzone,et al.  2265: AIRO PROS 01–04 Multi-Centric Study in Contouring CTV for Conformal Radiotherapy After Radical Prostatectomy , 2006 .

[7]  Patrick A Kupelian,et al.  Daily variations in the position of the prostate bed in patients with prostate cancer receiving postoperative external beam radiation therapy. , 2006, International journal of radiation oncology, biology, physics.

[8]  F. Burkhard,et al.  An extended pelvic lymph-node dissection should be performed in most patients if radical prostatectomy is truly indicated , 2006, Nature Clinical Practice Urology.

[9]  M. Zelefsky Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911) , 2006 .

[10]  Michel Bolla,et al.  Guidelines for primary radiotherapy of patients with prostate cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  J. Bosset,et al.  Conduite à tenir devant une ascension du PSA après rémission complète postprostatectomie , 2006 .

[12]  K. Haustermans,et al.  The role of whole pelvic radiotherapy in locally advanced prostate cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  D. Yan,et al.  Clinicopathologic analysis of extracapsular extension in prostate cancer: should the clinical target volume be expanded posterolaterally to account for microscopic extension? , 2004, International journal of radiation oncology, biology, physics.

[14]  J. Bosset,et al.  [What to do with a rising PSA after complete remission post-prostatectomy?]. , 2006, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[15]  Charlie Ma,et al.  Target localization for post‐prostatectomy patients using CT and ultrasound image guidance , 2005, Journal of applied clinical medical physics.

[16]  A. Pollack,et al.  Parameters for treatment decisions for salvage radiation therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  M. Piérart,et al.  Patients at high risk of progression after radical prostatectomy: do they all benefit from immediate post-operative irradiation? (EORTC trial 22911). , 2005, European journal of cancer.

[18]  M. Piérart,et al.  Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) , 2005, The Lancet.

[19]  S. Larson,et al.  2-[18F]Fluoro-2-Deoxyglucose Positron Emission Tomography for the Detection of Disease in Patients with Prostate-Specific Antigen Relapse after Radical Prostatectomy , 2005, Clinical Cancer Research.

[20]  N. Willich,et al.  Phase III results of adjuvant radiotherapy (RT) versus “wait and see” (WS) in patients with pT3 prostate cancer following radical prostatectomy (RP) (ARO 96–02/AUO AP 09/95) , 2005 .

[21]  A. Heidenreich,et al.  [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer]. , 2005, Aktuelle Urologie.

[22]  P. Walsh Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. , 2005, The Journal of urology.

[23]  C. Danjoux,et al.  Limited efficacy of salvage radiotherapy for biopsy confirmed or clinically palpable local recurrence of prostate carcinoma after surgery. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[24]  Franca Foppiano,et al.  Rectal and bladder motion during conformal radiotherapy after radical prostatectomy. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  Franca Foppiano,et al.  Anatomic Variations Due to Radical Prostatectomy , 2004, Strahlentherapie und Onkologie (Print).

[26]  F. Montorsi,et al.  Role of postoperative radiotherapy after pelvic lymphadenectomy and radical retropubic prostatectomy: a single institute experience of 415 patients. , 2004, International Journal of Radiation Oncology, Biology, Physics.

[27]  E. B. Butler,et al.  Predictors of Extracapsular Extension and Its Radial Distance in Prostate Cancer: Implications for Prostate IMRT, Brachytherapy, and Surgery , 2003, Cancer journal.

[28]  Rakesh Patel,et al.  3D-Ultrasound Guided Radiation Therapy in the Post-Prostatectomy Setting , 2003, Technology in cancer research & treatment.

[29]  Bulb of penis as a marker for prostatic apex in external beam radiotherapy of prostate cancer. , 2003, International journal of radiation oncology, biology, physics.

[30]  E. B. Butler,et al.  IMRT for prostate cancer: defining target volume based on correlated pathologic volume of disease. , 2003, International journal of radiation oncology, biology, physics.

[31]  F Fazio,et al.  Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography. , 2003, The Journal of urology.

[32]  Nobuyuki Oyama,et al.  11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  Jean-Yves Giraud,et al.  Quality assurance of the EORTC trial 22911. A phase III study of post-operative external radiotherapy in pathological stage T3N0 prostatic carcinoma: the dummy run. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  T. Wiegel,et al.  Computed Tomogram prior to Prostatectomy Advantage in Defining Planning Target Volumes for Postoperative Adjuvant Radiotherapy in Patients with Stage C Prostate Cancer? , 2002, Strahlentherapie und Onkologie.

[35]  C. Brunia,et al.  Wait and see. , 2001, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[36]  S. Shariat,et al.  Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings. , 2001, Radiology.

[37]  C. Catton,et al.  Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[38]  W. Sause,et al.  Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31). Radiation Therapy Oncology Group. , 1998, International journal of radiation oncology, biology, physics.

[39]  J. Silverman,et al.  MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy. , 1997, AJR. American journal of roentgenology.

[40]  P. Carroll,et al.  Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. , 1996, Urology.

[41]  W. Sause,et al.  Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31) , 1996 .

[42]  Icru Prescribing, recording, and reporting photon beam therapy , 1993 .

[43]  R. Flanigan,et al.  Radical prostatectomy: transrectal sonographic evaluation to assess for local recurrence. , 1993, Radiology.

[44]  P. Schellhammer,et al.  The effect of prior transurethral resection of the prostate on post radiation urethral strictures and bladder neck contractures. , 1986, International journal of radiation oncology, biology, physics.